Star Sports Medicine executes HK$1.27 million share buyback, cutting free float by 0.02%

Bulletin Express

Yesterday

Star Sports Medicine Co., Ltd. disclosed that it repurchased 11,000 H-shares on 09 September 2026 via the Hong Kong Stock Exchange, spending HK$1.27 million at prices ranging from HK$111.40 to HK$126.40 per share.

Following the transaction, the company’s issued share capital (excluding treasury shares) declined to 54.81 million, down from 54.82 million, representing a 0.02% reduction. Treasury shares increased to 21,600.

The repurchases form part of a mandate approved on 26 June 2026, which authorises the buyback of up to 5.48 million shares. Cumulative purchases under this mandate now total 21,600 shares, leaving capacity for a further 5.46 million shares.

Under Hong Kong listing rules, Star Sports Medicine is subject to a moratorium on issuing new shares or disposing of treasury shares until 09 October 2026. The company confirmed that the buyback complied with all applicable regulatory requirements.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrzen.com/news/1114674898"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1114674898\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1114674898?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-09-09 18:21","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1114674898","market":"hk","top_or_hot":-1,"title":"Star Sports Medicine executes HK$1.27 million share buyback, cutting free float by 0.02%","media":"Bulletin Express","content":"<p>Star Sports Medicine Co., Ltd. disclosed that it repurchased 11,000 H-shares on 09 September 2026 via the Hong Kong Stock Exchange, spending HK$1.27 million at prices ranging from HK$111.40 to HK$126.40 per share.</p>\n<p>Following the transaction, the company’s issued share capital (excluding treasury shares) declined to 54.81 million, down from 54.82 million, representing a 0.02% reduction. Treasury shares increased to 21,600.</p>\n<p>The repurchases form part of a mandate approved on 26 June 2026, which authorises the buyback of up to 5.48 million shares. Cumulative purchases under this mandate now total 21,600 shares, leaving capacity for a further 5.46 million shares.</p>\n<p>Under Hong Kong listing rules, Star Sports Medicine is subject to a moratorium on issuing new shares or disposing of treasury shares until 09 October 2026. The company confirmed that the buyback complied with all applicable regulatory requirements.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Star Sports Medicine executes HK$1.27 million share buyback, cutting free float by 0.02%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStar Sports Medicine executes HK$1.27 million share buyback, cutting free float by 0.02%\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-09-09 18:21</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Star Sports Medicine Co., Ltd. disclosed that it repurchased 11,000 H-shares on 09 September 2026 via the Hong Kong Stock Exchange, spending HK$1.27 million at prices ranging from HK$111.40 to HK$126.40 per share.</p>\n<p>Following the transaction, the company’s issued share capital (excluding treasury shares) declined to 54.81 million, down from 54.82 million, representing a 0.02% reduction. Treasury shares increased to 21,600.</p>\n<p>The repurchases form part of a mandate approved on 26 June 2026, which authorises the buyback of up to 5.48 million shares. Cumulative purchases under this mandate now total 21,600 shares, leaving capacity for a further 5.46 million shares.</p>\n<p>Under Hong Kong listing rules, Star Sports Medicine is subject to a moratorium on issuing new shares or disposing of treasury shares until 09 October 2026. The company confirmed that the buyback complied with all applicable regulatory requirements.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01609","symbol_name":"天星医疗","start_time":0,"source_url":"","article_id":"1114674898","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1114674898","pubTimestamp":1788949266,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Star Sports Medicine Co., Ltd. disclosed that it repurchased 11,000 H-shares on 09 September 2026 via the Hong Kong Stock Exchange, spending HK$1.27 million at prices ranging from HK$111.40 to...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01609":"天星医疗"},"translate_title":"Star Sports Medicine执行127万港元股份回购，自由流通量削减0.02%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01609":1},"content_text":"Star Sports Medicine Co., Ltd. disclosed that it repurchased 11,000 H-shares on 09 September 2026 via the Hong Kong Stock Exchange, spending HK$1.27 million at prices ranging from HK$111.40 to HK$126.40 per share.\nFollowing the transaction, the company’s issued share capital (excluding treasury shares) declined to 54.81 million, down from 54.82 million, representing a 0.02% reduction. Treasury shares increased to 21,600.\nThe repurchases form part of a mandate approved on 26 June 2026, which authorises the buyback of up to 5.48 million shares. Cumulative purchases under this mandate now total 21,600 shares, leaving capacity for a further 5.46 million shares.\nUnder Hong Kong listing rules, Star Sports Medicine is subject to a moratorium on issuing new shares or disposing of treasury shares until 09 October 2026. The company confirmed that the buyback complied with all applicable regulatory requirements.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}